Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of cancer pain: ESMO Clinical Practice Guidelines.

× No keyword cloud information.

10 in total

1. Efficacy and tolerability of oxycodone in moderate-severe cancer-related pain: A meta-analysis of randomized controlled trials.

Authors: Yu-Mei Wang; Zu-Wang Liu; Jia-Li Liu; Lei Zhang
Journal: Exp Ther Med Date: 2010-05-10 Impact factor: 2.447

2. A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain.

Authors: Sam H Ahmedzai; Friedemann Nauck; Gil Bar-Sela; Björn Bosse; Petra Leyendecker; Michael Hopp
Journal: Palliat Med Date: 2011-09-21 Impact factor: 4.762

3. A systematic and evidence-based approach to the management of vertebral metastasis.

Authors: Richard L S Jennelle; Vani Vijayakumar; Srinivasan Vijayakumar
Journal: ISRN Surg Date: 2011-08-02

4. Opioid switch from low dose of oral oxycodone to transdermal fentanyl matrix patch for patients with stable thoracic malignancy-related pain.

Authors: Seigo Minami; Takashi Kijima; Takeshi Nakatani; Suguru Yamamoto; Yoshitaka Ogata; Haruhiko Hirata; Takayuki Shiroyama; Taro Koba; Kiyoshi Komuta
Journal: BMC Palliat Care Date: 2014-10-08 Impact factor: 3.234

5. Iliofemoral Venous Thrombosis Mainly Related to Iliofemoral Venous Obstruction by External Tumor Compression in Cancer Patients.

Authors: Tzu-Yao Liao; Hui-Ching Hsu; Min-Sheng Wen; Yu-Hsiang Juan; Yu-Hsin Hung; Chuang-Chi Liaw
Journal: Case Rep Oncol Date: 2016-11-18

6. Opioid Use at End-Of-Life Among Nova Scotia Patients With Cancer.

Authors: Laura V Minard; Judith Fisher; Larry Broadfield; Gordon Walsh; Ingrid Sketris
Journal: Front Pharmacol Date: 2022-03-24 Impact factor: 5.810

Review 7. Data in longitudinal randomised controlled trials in cancer pain: is there any loss of the information available in the data? Results of a systematic literature review and guideline for reporting.

Authors: Odile Sauzet; Maren Kleine; John E Williams
Journal: BMC Cancer Date: 2016-10-06 Impact factor: 4.430

8. Medicine Availability and Prescribing Policy for Non-Communicable Diseases in the Western Balkan Countries.

Authors: Tanja Pekez-Pavlisko; Maja Racic; Srebrenka Kusmuk
Journal: Front Public Health Date: 2017-11-08

9. Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial.

Authors: Kyung-Hee Lee; Tae Won Kim; Jung-Hun Kang; Jin-Soo Kim; Jin-Seok Ahn; Sun-Young Kim; Hwan-Jung Yun; Young-Jun Eum; Sung Ae Koh; Min Kyoung Kim; Yong Sang Hong; Jeong Eun Kim; Gyeong-Won Lee
Journal: Chin J Cancer Date: 2017-09-11

10. An exploratory, large-scale study of pain and quality of life outcomes in cancer patients with moderate or severe pain, and variables predicting improvement.

Authors: Constanza Maximiano; Iker López; Cristina Martín; Luis Zugazabeitia; Juan L Martí-Ciriquián; Miguel A Núñez; Jorge Contreras; Michael Herdman; Susana Traseira; Mariano Provencio
Journal: PLoS One Date: 2018-04-03 Impact factor: 3.240

10 in total